AWM
NVO

Aberdeen Wealth Management’s Novo Nordisk NVO Stock Holding History

Aberdeen Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,040
Closed -$697K – 166
2025
Q1 		$697K Buy
10,040
+60
+0.6% +$4.96K 0.48% 64
2024
Q4 		$858K Hold
9,980
– – 0.59% 43
2024
Q3 		$1.19M Sell
9,980
-850
-8% -$113K 0.78% 34
2024
Q2 		$1.55M Hold
10,830
– – 1.05% 23
2024
Q1 		$1.39M Hold
10,830
– – 0.81% 33
2023
Q4 		$1.12M Hold
10,830
– – 0.81% 33
2023
Q3 		$985K Hold
10,830
– – 0.74% 37
2023
Q2 		$876K Hold
10,830
– – 0.63% 40
2023
Q1 		$862K Sell
10,830
-270
-2% -$19.1K 0.64% 41
2022
Q4 		$751K Hold
11,100
– – 0.57% 49
2022
Q3 		$553K Hold
11,100
– – 0.49% 61
2022
Q2 		$618K Sell
11,100
-600
-5% -$33.3K 0.49% 57
2022
Q1 		$650K Hold
11,700
– – 0.44% 68
2021
Q4 		$655K Sell
11,700
-250
-2% -$13.5K 0.43% 66
2021
Q3 		$574K Sell
11,950
-100
-0.8% -$4.83K 0.56% 61
2021
Q2 		$505K Hold
12,050
– – 0.47% 72
2021
Q1 		$406K Hold
12,050
– – 0.32% 95
2020
Q4 		$421K Hold
12,050
– – 0.32% 84
2020
Q3 		$418K Sell
12,050
-1,808
-13% -$60.3K 0.4% 74
2020
Q2 		$454K Buy
13,858
+1,638
+13% +$52.3K 0.49% 70
2020
Q1 		$368K Hold
12,220
– – 0.45% 70
2019
Q4 		$354K Buy
+12,220
New +$338K 0.26% 97

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aberdeen Wealth Management's NVO Position: Q2 2025 in Review

Aberdeen Wealth Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 10,040 shares — an estimated $697K sold.

Aberdeen Wealth Management first reported a position in NVO in Q4 2019 and held it in 22 quarters. The position peaked at $1.55M in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Aberdeen Wealth Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Aberdeen Wealth Management sold 10,040 Novo Nordisk shares in Q2 2025, an estimated $697K.
  • Aberdeen Wealth Management first reported a position in Novo Nordisk in Q4 2019 and held it in 22 quarters.
  • Aberdeen Wealth Management's Novo Nordisk position peaked at $1.55M in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Aberdeen Wealth Management's 13F filing for Q2 2025, filed 14 Aug 2025.